About this Journal Submit a Manuscript Table of Contents
The Scientific World Journal
Volume 2012 (2012), Article ID 357475, 9 pages
http://dx.doi.org/10.1100/2012/357475
Review Article

Surgical Treatment of Sporadic Pancreatic Neuroendocrine Tumors: A State of the Art Review

1Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
2Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
3Interventional Centre, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway

Received 12 October 2012; Accepted 25 November 2012

Academic Editors: Y. Motoo and P. Zezos

Copyright © 2012 Sven-Petter Haugvik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Halfdanarson, K. G. Rabe, J. Rubin, and G. M. Petersen, “Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival,” Annals of Oncology, vol. 19, no. 10, pp. 1727–1733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Milan and C. J. Yeo, “Neuroendocrine tumors of the pancreas,” Current Opinion in Oncology, vol. 24, no. 1, pp. 46–55, 2012.
  3. K. Öberg, “Pancreatic endocrine tumors,” Seminars in Oncology, vol. 37, no. 6, pp. 594–618, 2010. View at Publisher · View at Google Scholar
  4. G. Rindi and B. Wiedenmann, “Neuroendocrine neoplasms of the gut and pancreas: new insights,” Nature Reviews Endocrinology, vol. 8, pp. 54–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Yao, M. Hassan, A. Phan et al., “One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States,” Journal of Clinical Oncology, vol. 26, no. 18, pp. 3063–3072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Kimura, A. Kuroda, and Y. Morioka, “Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases,” Digestive Diseases and Sciences, vol. 36, no. 7, pp. 933–942, 1991. View at Scopus
  7. M. H. Kulke, J. Bendell, L. Kvols, J. Picus, R. Pommier, and J. Yao, “Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors,” Journal of Hematology and Oncology, vol. 4, article no. 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Dralle, S. L. Krohn, W. Karges, B. O. Boehm, M. Brauckhoff, and O. Gimm, “Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors,” World Journal of Surgery, vol. 28, no. 12, pp. 1248–1260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Fendrich, J. Waldmann, D. K. Bartsch, and P. Langer, “Surgical management of pancreatic endocrine tumors,” Nature Reviews Clinical Oncology, vol. 6, no. 7, pp. 419–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. B. Evans, J. M. Skibber, J. E. Lee et al., “Nonfunctioning islet cell carcinoma of the pancreas,” Surgery, vol. 114, no. 6, pp. 1175–1182, 1993. View at Scopus
  11. H. Liang, P. Wang, X. N. Wang, J. C. Wang, and X. S. Hao, “Management of nonfunctioning islet cell tumors,” World Journal of Gastroenterology, vol. 10, no. 12, pp. 1806–1809, 2004. View at Scopus
  12. D. K. Bartsch, T. Schilling, A. Ramaswamy et al., “Management of nonfunctioning islet cell carcinomas,” World Journal of Surgery, vol. 24, no. 11, pp. 1418–1424, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. I. M. Modlin, S. F. Moss, B. I. Gustafsson, B. Lawrence, S. Schimmack, and M. Kidd, “The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant,” Langenbeck's Archives of Surgery, vol. 396, pp. 1145–1156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Rindi, M. Falconi, C. Klersy et al., “TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study,” Journal of the National Cancer Institute, vol. 104, no. 10, pp. 764–777, 2012. View at Publisher · View at Google Scholar
  15. G. Rindi, G. Klöppel, and H. Alhman, “TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system,” Virchows Archiv, vol. 449, no. 4, pp. 395–401, 2006. View at Publisher · View at Google Scholar
  16. F. Ehehalt, H. D. Saeger, C. M. Schmidt, and R. Grützmann, “Neuroendocrine tumors of the pancreas,” Oncologist, vol. 14, no. 5, pp. 456–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. F. T. Bosman, F. Carneiro, and R. H. Hruban, WHO Classification of Tumours of the Digestive System, International Agency for Research on Cancer (IARC), Lyon, France, 2010.
  18. G. Rindi, “The ENETS guidelines: the new TNM classification system,” Tumori, vol. 96, no. 5, pp. 806–809, 2010. View at Scopus
  19. S. Ekeblad, B. Skogseid, K. Dunder, K. Oberg, and B. Eriksson, “Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution,” Clinical Cancer Research, vol. 14, no. 23, pp. 7798–7803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ito, M. Abramson, K. Ito et al., “Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience,” Journal of Gastrointestinal Surgery, vol. 14, no. 5, pp. 891–898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Pomianowska, I. P. Gladhaug, K. Grzyb et al., “Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems,” Scandinavian Journal of Gastroenterology, vol. 45, no. 7-8, pp. 971–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Scarpa, W. Mantovani, P. Capelli et al., “Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients,” Modern Pathology, vol. 23, no. 6, pp. 824–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Gomez-Rivera, A. E. Stewart, J. P. Arnoletti, S. Vickers, K. I. Bland, and M. J. Heslin, “Surgical treatment of pancreatic endocrine neoplasms,” American Journal of Surgery, vol. 193, no. 4, pp. 460–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Legaspi, M. F. Brennan, R. A. Prinz et al., “Management of islet cell carcinoma,” Surgery, vol. 104, no. 6, pp. 1018–1023, 1988. View at Scopus
  25. K. K. Kazanjian, H. A. Reber, and O. J. Hines, “Resection of pancreatic neuroendocrine tumors: results of 70 cases,” Archives of Surgery, vol. 141, no. 8, pp. 765–769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Zerbi, V. Capitanio, L. Boninsegna et al., “Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases,” Langenbeck's Archives of Surgery, vol. 396, no. 3, pp. 313–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. D. Matthews, T. I. Smith, K. W. Kercher, W. D. Holder, and B. T. Heniford, “Surgical experience with functioning pancreatic neuroendocrine tumors,” American Surgeon, vol. 68, no. 8, pp. 660–665, 2002. View at Scopus
  28. C. S. Grant, “Surgical management of malignant islet cell tumors,” World Journal of Surgery, vol. 17, no. 4, pp. 498–503, 1993. View at Scopus
  29. D. Grama, B. Eriksson, H. Martensson et al., “Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes,” World Journal of Surgery, vol. 16, no. 4, pp. 632–639, 1992. View at Scopus
  30. S. Crippa, A. Zerbi, L. Boninsegna et al., “Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections,” Archives of Surgery, vol. 147, no. 3, pp. 261–266, 2012. View at Publisher · View at Google Scholar
  31. M. Rothmund, L. Angelini, L. M. Brunt et al., “Surgery for benign insulinoma: an international review,” World Journal of Surgery, vol. 14, no. 3, pp. 393–399, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Vaidakis, J. Karoubalis, T. Pappa, G. Piaditis, and G. N. Zografos, “Pancreatic insulinoma: current issues and trends,” Hepatobiliary and Pancreatic Diseases International, vol. 9, no. 3, pp. 234–241, 2010. View at Scopus
  33. A. Sa Cunha, A. Rault, C. Beau, D. Collet, and B. Masson, “Laparoscopic central pancreatectomy: single institution experience of 6 patients,” Surgery, vol. 142, no. 3, pp. 405–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Falconi, A. Zerbi, S. Crippa et al., “Parenchyma-Preserving resections for small nonfunctioning pancreatic endocrine tumors,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1621–1627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. P. Zhao, H. X. Zhan, T. P. Zhang et al., “Surgical management of patients with insulinomas: result of 292 cases in a single institution,” Journal of Surgical Oncology, vol. 103, no. 2, pp. 169–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Hirshberg, S. K. Libutti, H. R. Alexander et al., “Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure,” Journal of the American College of Surgeons, vol. 194, no. 6, pp. 761–764, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. Norton, T. H. Shawker, J. L. Doppman et al., “Localization and surgical treatment of occult insulinomas,” Annals of Surgery, vol. 212, no. 5, pp. 615–620, 1990. View at Scopus
  38. E. C. Ellison, J. Sparks, J. S. Verducci et al., “50-year appraisal of gastrinoma: recommendations for staging and treatment,” Journal of the American College of Surgeons, vol. 202, no. 6, pp. 897–905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Norton, D. L. Fraker, H. R. Alexander et al., “Surgery to cure the Zollinger-Ellison syndrome,” The New England Journal of Medicine, vol. 341, no. 9, pp. 635–644, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. J. A. Norton, H. R. Alexander, D. L. Fraker et al., “Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?” Annals of Surgery, vol. 239, no. 5, pp. 617–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. F. E. Eckhauser, P. S. Cheung, and A. I. Vinik, “Nonfunctioning malignant neuroendocrine tumors of the pancreas,” Surgery, vol. 100, no. 6, pp. 978–988, 1986. View at Scopus
  42. R. Bettini, S. Partelli, L. Boninsegna et al., “Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor,” Surgery, vol. 150, no. 1, pp. 75–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Fernández-Cruz, V. Molina, R. Vallejos, E. Jiménez Chavarria, M.-A. Lõpez-Boado, and J. Ferrer, “Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours,” HPB, vol. 14, no. 3, pp. 171–176, 2012. View at Publisher · View at Google Scholar
  44. F. Panzuto, L. Boninsegna, N. Fazio et al., “Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression,” Journal of Clinical Oncology, vol. 29, no. 17, pp. 2372–2377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Kinoshita, T. Minami, Y. Ohmori, S. Kanayama, K. Yoshikawa, and T. Tsujimura, “Curative resection of a small cell carcinoma of the pancreas: report of a case of long survival without chemotherapy,” Journal of Gastroenterology and Hepatology, vol. 19, no. 9, pp. 1087–1091, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. T. P. O'Connor, T. P. Wade, Y. C. Sunwoo et al., “Small cell undifferentiated carcinoma of the pancreas: report of a patient with tumor marker studies,” Cancer, vol. 70, no. 6, pp. 1514–1519, 1992. View at Scopus
  47. C. V. Reyes and T. Wang, “Undifferentiated small cell carcinoma of the pancreas: a report of five cases,” Cancer, vol. 47, no. 10, pp. 2500–2502, 1981. View at Scopus
  48. O. Nilsson, E. Van Cutsem, G. Delle Fave et al., “Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic),” Neuroendocrinology, vol. 84, no. 3, pp. 212–215, 2007. View at Publisher · View at Google Scholar
  49. L. Kölby, O. Nilsson, and H. Ahlman, “Gastroduodenal endocrine tumours,” Scandinavian Journal of Surgery, vol. 93, no. 4, pp. 317–323, 2004. View at Scopus
  50. G. Åkerström, “Management of carcinoid tumors of the stomach, duodenum, and pancreas,” World Journal of Surgery, vol. 20, no. 2, pp. 173–182, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Abu Hilal, M. J. W. McPhail, B. A. Zeidan, C. E. Jones, C. D. Johnson, and N. W. Pearce, “Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?” Journal of the Pancreas, vol. 10, no. 3, pp. 276–279, 2009. View at Scopus
  52. J. A. Norton, M. Kivlen, M. Li et al., “Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors,” Archives of Surgery, vol. 138, no. 8, pp. 859–866, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Hellman, M. Andersson, J. Rastad et al., “Surgical strategy for large or malignant endocrine pancreatic tumors,” World Journal of Surgery, vol. 24, no. 11, pp. 1353–1360, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. J. S. Hill, J. T. McPhee, T. P. McDade et al., “Pancreatic neuroendocrine tumors,” Cancer, vol. 115, no. 4, pp. 741–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. E. S. Glazer, J. F. Tseng, W. Al-Refaie et al., “Long-term survival after surgical management of neuroendocrine hepatic metastases,” HPB, vol. 12, no. 6, pp. 427–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Bruzoni, P. Parikh, R. Celis et al., “Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review,” American Journal of Surgery, vol. 197, no. 3, pp. 376–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. S. Chamberlain, D. Canes, K. T. Brown et al., “Hepatic neuroendocrine metastases: does intervention alter outcomes?” Journal of the American College of Surgeons, vol. 190, no. 4, pp. 432–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. C. S. Cho, D. M. Labow, L. Tang et al., “Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms,” Cancer, vol. 113, no. 1, pp. 126–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Chen, J. M. Hardacre, A. Uzar, J. L. Cameron, and M. A. Choti, “Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?” Journal of the American College of Surgeons, vol. 187, no. 1, pp. 88–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Musunuru, H. Chen, S. Rajpal et al., “Metastatic neuroendocrine hepatic tumors: resection improves survival,” Archives of Surgery, vol. 141, no. 10, pp. 1000–1004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. F. G. Que, D. M. Nagorney, K. P. Batts, L. J. Linz, and L. K. Kvols, “Hepatic resection for metastatic neuroendocrine carcinomas,” American Journal of Surgery, vol. 169, no. 1, pp. 36–43, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Capurso, R. Bettini, M. Rinzivillo, L. Boninsegna, G. D. Fave, and M. Falconi, “Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review,” Neuroendocrinology, vol. 93, no. 4, pp. 223–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. C. Mayo, M. C. De Jong, C. Pulitano et al., “Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis,” Annals of Surgical Oncology, vol. 17, no. 12, pp. 3129–3136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Scigliano, R. Lebtahi, F. Maire et al., “Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience,” Endocrine-Related Cancer, vol. 16, no. 3, pp. 977–990, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Cusati, L. Zhang, W. S. Harmsen et al., “Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes,” Journal of the American College of Surgeons, vol. 215, no. 1, pp. 117–124, 2012. View at Publisher · View at Google Scholar
  66. B. Dousset, O. Saint-Marc, J. Pitre, O. Soubrane, D. Houssin, and Y. Chapuis, “Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation,” World Journal of Surgery, vol. 20, no. 7, pp. 908–915, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Elias, P. Lasser, M. Ducreux et al., “Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study,” Surgery, vol. 133, no. 4, pp. 375–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Kianmanesh, A. Sauvanet, O. Hentic et al., “Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection,” Annals of Surgery, vol. 247, no. 4, pp. 659–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. M. Sarmiento, G. Heywood, J. Rubin, D. M. Ilstrup, D. M. Nagorney, and F. G. Que, “Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. J. M. Sarmiento and F. G. Que, “Hepatic surgery for metastases from neuroendocrine tumors,” Surgical Oncology Clinics of North America, vol. 12, no. 1, pp. 231–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. G. B. Thompson, J. A. Van Heerden, C. S. Grant, J. A. Carney, and D. M. Ilstrup, “Islet cell carcinomas of the pancreas: a twenty-year experience,” Surgery, vol. 104, no. 6, pp. 1011–1017, 1988. View at Scopus
  72. G. L. Grazi, M. Cescon, F. Pierangeli et al., “Highly aggressive policy of hepatic resections for neuroendocrine liver metastases,” Hepato-Gastroenterology, vol. 47, no. 32, pp. 481–486, 2000. View at Scopus
  73. C. Bassi, “Middle segment pancreatectomy: a useful tool in the management of pancreatic neoplasms,” Journal of Gastrointestinal Surgery, vol. 11, no. 4, pp. 421–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Hackert, U. Hinz, S. Fritz et al., “Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections,” Langenbeck's Archives of Surgery, vol. 396, pp. 1197–1203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Crippa, C. Bassi, R. Salvia, M. Falconi, G. Butturini, and P. Pederzoli, “Enucleation of pancreatic neoplasms,” British Journal of Surgery, vol. 94, no. 10, pp. 1254–1259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Dedieu, A. Rault, D. Collet, B. Masson, and A. Sa Cunha, “Laparoscopic enucleation of pancreatic neoplasm,” Surgical Endoscopy and Other Interventional Techniques, vol. 25, no. 2, pp. 575–576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. J. DiNorcia, M. K. Lee, P. L. Reavey et al., “One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques,” Journal of Gastrointestinal Surgery, vol. 14, no. 10, pp. 1536–1546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Assalia and M. Gagner, “Laparoscopic pancreatic surgery for islet cell tumors of the pancreas,” World Journal of Surgery, vol. 28, no. 12, pp. 1239–1247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Edwin, T. Mala, O. Mathisen et al., “Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome,” Surgical Endoscopy and Other Interventional Techniques, vol. 18, no. 3, pp. 407–411, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Fernández-Cruz, M. Herrera, A. Sáenz, J. P. Pantoja, E. Astudillo, and M. Sierra, “Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits,” Best Practice and Research, vol. 15, no. 2, pp. 161–175, 2001. View at Publisher · View at Google Scholar
  81. M. Gagner, A. Pomp, M. F. Herrera et al., “Early experience with laparoscopic resections of islet cell tumors,” Surgery, vol. 120, no. 6, pp. 1051–1054, 1996. View at Scopus
  82. P. Limongelli, A. Belli, G. Russo et al., “Laparoscopic and open surgical treatment of left-sided pancreatic lesions: clinical outcomes and cost-effectiveness analysis,” Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 7, pp. 1830–1836, 2012. View at Publisher · View at Google Scholar
  83. S. C. Kim, K. T. Park, J. W. Hwang et al., “Comparative analysis of clinical outcomes for laparoscopic distal pancreatic resection and open distal pancreatic resection at a single institution,” Surgical Endoscopy and Other Interventional Techniques, vol. 22, no. 10, pp. 2261–2268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. M. S. Baker, D. J. Bentrem, M. B. Ujiki, S. Stocker, and M. S. Talamonti, “A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy,” Surgery, vol. 146, no. 4, pp. 635–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. D. A. Kooby, W. G. Hawkins, C. M. Schmidt et al., “Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution,” Journal of the American College of Surgeons, vol. 210, no. 5, pp. 779–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Fernández-Cruz, R. Cosa, L. Blanco, S. Levi, M. A. López-Boado, and S. Navarro, “Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution,” Journal of Gastrointestinal Surgery, vol. 11, no. 12, pp. 1607–1622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Y. Mabrut, L. Fernandez-Cruz, J. S. Azagra et al., “Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients,” Surgery, vol. 137, no. 6, pp. 597–605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. B. W. Eom, J. Y. Jang, S. E. Lee, H. S. Han, Y. S. Yoon, and S. W. Kim, “Clinical outcomes compared between laparoscopic and open distal pancreatectomy,” Surgical Endoscopy and Other Interventional Techniques, vol. 22, no. 5, pp. 1334–1338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. A. Hilal, M. Hamdan, F. Di Fabio, N. W. Pearce, and C. D. Johnson, “Laparoscopic versus open distal pancreatectomy: a clinical and cost-effectiveness study,” Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 6, pp. 1670–1674, 2012. View at Publisher · View at Google Scholar
  90. D. A. Kooby, T. Gillespie, D. Bentrem et al., “Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches,” Annals of Surgery, vol. 248, no. 3, pp. 438–443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. B. I. Røsok, I. P. Marangos, A. M. Kazaiyan et al., “Single-centre experience of laparoscopic pancreatic surgery,” British Journal of Surgery, vol. 97, no. 6, pp. 902–909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. P. J. Kneuertz, S. H. Patel, C. K. Chu et al., “Laparoscopic distal pancreatectomy: trends and lessons learned through an 11-year experience,” Journal of the American College of Surgeons, vol. 215, no. 2, pp. 167–176, 2012. View at Publisher · View at Google Scholar
  93. A. M. Fox, K. Pitzul, F. Bhojani et al., “Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center,” Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 5, pp. 1220–1230, 2012. View at Publisher · View at Google Scholar
  94. G. Butturini, S. Partelli, S. Crippa et al., “Perioperative and long-term results after left pancreatectomy: a single-institution, non-randomized, comparative study between open and laparoscopic approach,” Surgical Endoscopy, vol. 25, pp. 2871–2878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Butturini, M. Inama, G. Malleo et al., “Perioperative and long-term results of laparoscopic spleen-preserving distal pancreatectomy with or without splenic vessels conservation: a retrospective analysis,” Journal of Surgical Oncology, vol. 105, no. 4, pp. 387–392, 2012. View at Publisher · View at Google Scholar
  96. N. Singh, C. Y. Lo, and W. F. Chan, “Laparoscopic enucleation of a nonfunctioning neuroendocrine tumor at the head of the pancreas,” JSLS, vol. 10, no. 2, pp. 259–262, 2006. View at Scopus
  97. S. C. Kim, K. B. Song, Y. S. Jung, et al., “Short-term clinical outcomes for 100 consecutive cases of laparoscopic pylorus-preserving pancreatoduodenectomy: improvement with surgical experience,” Surgical Endoscopy. In press.
  98. L. Fernández-Cruz and G. Cesar-Borges, “Laparoscopic strategies for resection of insulinomas,” Journal of Gastrointestinal Surgery, vol. 10, no. 5, pp. 752–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Toniato, F. Meduri, M. Foletto, A. Avogaro, and M. Pelizzo, “Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experience,” World Journal of Surgery, vol. 30, no. 10, pp. 1916–1919, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Murakami, K. Uemura, T. Sudo et al., “Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma,” Journal of the American College of Surgeons, vol. 211, no. 2, pp. 196–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. T. T. Sahin, T. Fujii, M. Kanda et al., “Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas,” Pancreas, vol. 40, pp. 1029–1033, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Pomianowska, A. Westgaard, O. Mathisen, et al., “Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas,” Annals of Surgical Oncology. In press.
  103. L. Boninsegna, F. Panzuto, S. Partelli, et al., “Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections,” European Journal of Cancer, vol. 48, no. 11, pp. 1608–1615, 2012.
  104. P. Tomassetti, D. Campana, L. Piscitelli et al., “Endocrine pancreatic tumors: factors correlated with survival,” Annals of Oncology, vol. 16, no. 11, pp. 1806–1810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. J. R. Parekh, S. C. Wang, E. K. Bergsland et al., “Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the ucsf experience with 149 patients,” Pancreas, vol. 41, no. 6, pp. 840–844, 2012. View at Publisher · View at Google Scholar
  106. M. Ouaissi, C. Hubert, R. Verhelst et al., “Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure,” World Journal of Surgery, vol. 34, no. 11, pp. 2648–2661, 2010. View at Scopus
  107. T. Akatsu, K. Aiura, M. Shimazu et al., “Successful pancreatectomy with En-bloc resection of the celiac artery and portal vein for pancreatic endocrine carcinoma,” Hepato-Gastroenterology, vol. 54, no. 76, pp. 1269–1271, 2007. View at Scopus
  108. A. Bedirli, T. E. Patiroglu, O. Sakrak, and Y. Aritas, “Portal vein resection for a portal vein thrombus caused by nonfunctioning islet cell carcinoma: report of a case,” Surgery Today, vol. 34, no. 9, pp. 802–804, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Sakamoto, H. Hasegawa, S. Ogiso et al., “Curative resection for a pancreatic endocrine carcinoma involving the portal vein,” Hepato-Gastroenterology, vol. 51, no. 60, pp. 1849–1851, 2004. View at Scopus
  110. J. A. Norton, E. J. Harris, Y. Chen et al., “Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection,” Archives of Surgery, vol. 146, no. 6, pp. 724–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. G. Q. Phan, C. J. Yeo, R. H. Hruban, K. D. Lillemoe, H. A. Pitt, and J. L. Cameron, “Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients,” Journal of Gastrointestinal Surgery, vol. 2, no. 5, pp. 473–482, 1998. View at Scopus
  112. Q. D. Chu, H. C. Hill, H. O. Douglass et al., “Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas,” Annals of Surgical Oncology, vol. 9, no. 9, pp. 855–862, 2002. View at Scopus
  113. R. T. Jensen, G. Cadiot, M. L. Brandi et al., “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes,” Neuroendocrinology, vol. 95, no. 2, pp. 98–119, 2012. View at Publisher · View at Google Scholar
  114. M. Falconi, D. K. Bartsch, B. Eriksson et al., “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors,” Neuroendocrinology, vol. 95, no. 2, pp. 120–134, 2012. View at Publisher · View at Google Scholar
  115. E. T. Janson, H. Sørbye, S. Welin et al., “Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours,” Acta Oncologica, vol. 49, no. 6, pp. 740–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. M. H. Kulke, L. B. Anthony, D. L. Bushnell et al., “NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas,” Pancreas, vol. 39, no. 6, pp. 735–752, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. M. A. Kouvaraki, C. C. Solorzano, S. E. Shapiro et al., “Surgical treatment of non-functioning pancreatic islet cell tumors,” Journal of Surgical Oncology, vol. 89, no. 3, pp. 170–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. S. L. Ong, G. Garcea, C. A. Pollard et al., “A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome,” Pancreatology, vol. 9, no. 5, pp. 583–600, 2009. View at Publisher · View at Google Scholar · View at Scopus